BAAM
ABMD

Baker Avenue Asset Management’s Abiomed Inc ABMD Stock Holding History

Baker Avenue Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-8,455
Closed -$2.04M – 245
2020
Q2 		$2.04M Hold
8,455
– – 0.17% 85
2020
Q1 		$1.23M Sell
8,455
-72
-0.8% -$12K 0.15% 67
2019
Q4 		$1.45M Buy
+8,527
New +$1.58M 0.11% 124
2019
Q2 		– Sell
-4,627
Closed -$1.32M – 254
2019
Q1 		$1.32M Buy
+4,627
New +$1.54M 0.11% 118

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baker Avenue Asset Management's ABMD Position: Q3 2020 in Review

Baker Avenue Asset Management sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 8,455 shares — an estimated $2.04M sold.

Baker Avenue Asset Management first reported a position in ABMD in Q1 2019 and held it in 4 quarters. The position peaked at $2.04M in Q2 2020. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

  • Baker Avenue Asset Management reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
  • Baker Avenue Asset Management sold 8,455 Abiomed Inc shares in Q3 2020, an estimated $2.04M.
  • Baker Avenue Asset Management first reported a position in Abiomed Inc in Q1 2019 and held it in 4 quarters.
  • Baker Avenue Asset Management's Abiomed Inc position peaked at $2.04M in Q2 2020.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Baker Avenue Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.